|
|
|
|
LEADER |
00000nam a22000005i 4500 |
001 |
978-0-387-25752-5 |
003 |
DE-He213 |
005 |
20220119100224.0 |
007 |
cr nn 008mamaa |
008 |
100301s2005 xxu| s |||| 0|eng d |
020 |
|
|
|a 9780387257525
|9 978-0-387-25752-5
|
024 |
7 |
|
|a 10.1007/b135898
|2 doi
|
050 |
|
4 |
|a HD87-87.55
|
072 |
|
7 |
|a KCP
|2 bicssc
|
072 |
|
7 |
|a POL024000
|2 bisacsh
|
072 |
|
7 |
|a KCP
|2 thema
|
082 |
0 |
4 |
|a 338.9
|2 23
|
245 |
1 |
0 |
|a Improving Healthcare
|h [electronic resource] :
|b A Dose of Competition /
|c edited by David Hyman.
|
246 |
3 |
|
|a Report By The Federal Trade Commission and Department of Justice (July, 2004), with various Supplementary Materials
|
250 |
|
|
|a 1st ed. 2005.
|
264 |
|
1 |
|a New York, NY :
|b Springer US :
|b Imprint: Springer,
|c 2005.
|
300 |
|
|
|a XV, 431 p.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a Developments in Health Economics and Public Policy ;
|v 9
|
505 |
0 |
|
|a Executive Summary -- Overview/Background -- Industry Snapshot and Competition Law: Physicians -- Industry Snapshot: Hospitals -- Competition Law: Hospitals -- Industry Snapshot: Insurance and Other Third Party Payment Programs -- 6: Competition Law: Insurers -- Industry Snapshot and Competition Law: Pharmaceuticals -- Miscellaneous Subjects.
|
520 |
|
|
|a Improving Healthcare: A Dose of Competition systematically examines the American health care system from a competition-oriented perspective. The volume surveys the performance of each major sector of the health care system, and identifies impediments to more effective competition. Improving Healthcare examines such issues as competition v. regulation, public and private sector approaches to health care financing, cross-subsidies, licensure, provider market concentration, financial and clinical integration, payment for performance, quality, pharmacy benefit managers, direct-to-consumer advertising of pharmaceuticals, certificates of need, mandates, unionization, the significance of organizational status (nonprofit v. for-profit), and the role of antitrust and consumer protection in health care. It offers concrete recommendations to improve the quality and cost-effectiveness of the American health care marketplace.
|
650 |
|
0 |
|a Economic policy.
|
650 |
|
0 |
|a Law and economics.
|
650 |
|
0 |
|a Medical laws and legislation.
|
650 |
|
0 |
|a Medical informatics.
|
650 |
|
0 |
|a Social policy.
|
650 |
1 |
4 |
|a Economic Policy.
|
650 |
2 |
4 |
|a Law and Economics.
|
650 |
2 |
4 |
|a Medical Law.
|
650 |
2 |
4 |
|a Health Informatics.
|
650 |
2 |
4 |
|a Social Policy.
|
700 |
1 |
|
|a Hyman, David.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer Nature eBook
|
776 |
0 |
8 |
|i Printed edition:
|z 9780387506906
|
776 |
0 |
8 |
|i Printed edition:
|z 9780387257518
|
776 |
0 |
8 |
|i Printed edition:
|z 9781461498162
|
830 |
|
0 |
|a Developments in Health Economics and Public Policy ;
|v 9
|
856 |
4 |
0 |
|u https://doi.uam.elogim.com/10.1007/b135898
|z Texto Completo
|
912 |
|
|
|a ZDB-2-SBE
|
912 |
|
|
|a ZDB-2-SXEF
|
950 |
|
|
|a Business and Economics (SpringerNature-11643)
|
950 |
|
|
|a Economics and Finance (R0) (SpringerNature-43720)
|